29588 Federal Register / Vol. 86, No. 104 / Wednesday, June 2, 2021 / Notices 

HRSA specifically requests comments 

on: (1) The necessity and utility of the 

proposed information collection for the 

proper performance of the agency’s 

functions, (2) the accuracy of the 

estimated burden, (3) ways to enhance 

the quality, utility, and clarity of the 

information to be collected, and (4) the 

use of automated collection techniques 

or other forms of information 

technology to minimize the information 

collection burden. 

Maria G. Button, 

Director, Executive Secretariat. 

[FR Doc. 2021–11542 Filed 6–1–21; 8:45 am] 

BILLING CODE 4165–15–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Health Resources and Services 

Administration 

Meeting of the Advisory Committee on 

Infant Mortality 

AGENCY: Health Resources and Services 

Administration (HRSA), Department of 

Health and Human Services (HHS). 

ACTION: Notice. 

SUMMARY: In accordance with the 

Federal Advisory Committee Act, this 

notice announces that the Advisory 

Committee on Infant Mortality (ACIM) 

has scheduled a public meeting. 

Information about ACIM and the agenda 

for this meeting can be found on the 

ACIM website at https://www.hrsa.gov/ 

advisory-committees/infant-mortality/ 

index.html. 

DATES: June 22, 2021, 12:00 p.m.–4:00 

p.m. Eastern Time (ET) and June 23, 

2021, 12:00 p.m.–4:00 p.m. ET. 

ADDRESSES: This meeting will be held 

via webinar. The webinar link and login information will be available at 

ACIM’s website before the meeting: 

https://www.hrsa.gov/advisorycommittees/infant-mortality/index.html. 

FOR FURTHER INFORMATION CONTACT: 

Vanessa Lee, MPH, Acting Designated 

Federal Official, Maternal and Child 

Health Bureau, HRSA, 5600 Fishers 

Lane, Rockville, Maryland 20857; 301– 

443–0543; or SACIM@hrsa.gov. 

SUPPLEMENTARY INFORMATION: The ACIM 

is authorized by section 222 of the 

Public Health Service Act (42 U.S.C. 

217a), as amended. The Committee is 

governed by provisions of Public Law 

92–463, as amended, (5 U.S.C. App. 2), 

which sets forth standards for the 

formation and use of Advisory 

Committees. 

The ACIM advises the Secretary of 

HHS on department activities and 

programs directed at reducing infant 

mortality and improving the health 

status of pregnant women and infants. 

The ACIM represents a public-private 

partnership at the highest level to 

provide guidance and focus attention on 

the policies and resources required to 

address the reduction of infant mortality 

and the improvement of the health 

status of pregnant women and infants. 

With a focus on life course, the ACIM 

addresses disparities in maternal health 

to improve maternal health outcomes, 

including preventing and reducing 

maternal mortality and severe maternal 

morbidity. The ACIM provides advice 

on how best to coordinate myriad 

federal, state, local, and private 

programs and efforts that are designed 

to deal with the health and social 

problems impacting infant mortality and 

maternal health, including 

implementation of the Healthy Start 

program and maternal and infant health 

objectives from the National Health 

Promotion and Disease Prevention 

Objectives (i.e., Healthy People 2030). 

The agenda for the June 22–23, 2021, 

meeting is being finalized and may 

include the following topics: Discussion 

of recommendations by ACIM to the 

Secretary; updates from HRSA’s 

Maternal and Child Health Bureau, and 

other federal agencies; the Centers for 

Disease Control and Prevention’s 

Pregnancy Risk Assessment Monitoring 

System survey; and patient-physician 

racial concordance in health care. 

Agenda items are subject to change as 

priorities dictate. Refer to the ACIM 

website for any updated information 

concerning the meeting. 

Members of the public will have the 

opportunity to provide written or oral 

comments. Requests to submit a written 

statement or make oral comments to the 

ACIM should be sent to Vanessa Lee, 

using the email address above at least 3 

business days prior to the meeting. 

Public participants may submit written 

statements in advance of the scheduled 

meeting by emailing SACIM@hrsa.gov. 

Oral comments will be honored in the 

order they are requested and may be 

limited as time allows. 

Individuals who plan to attend and 

need special assistance or another 

reasonable accommodation should 

notify Vanessa Lee at the contact 

information listed above at least 10 

business days prior to the meeting. 

Maria G. Button, 

Director, Executive Secretariat. 

[FR Doc. 2021–11504 Filed 6–1–21; 8:45 am] 

BILLING CODE 4165–15–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health. 

National Institute of Neurological 

Disorders and Stroke; Notice of Closed 

Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Neurological Disorders and Stroke Special 

Emphasis Panel; Music and Health. 

Date: June 24, 2021. 

Time: 9:00 a.m. to 6:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Neuroscience Center, 6001 Executive 

Boulevard, Rockville, MD 20852 (Virtual 

Meeting). 

Contact Person: W. Ernest Lyons, PhD, 

Scientific Review Administrator, Scientific 

Review Branch, NINDS/NIH/DHHS, 

Neuroscience Center, 6001 Executive Blvd., 

Suite 3208, MSC 9529, Rockville, MD 20852, 

301–496–4056, lyonse@ninds.nih.gov. 

Name of Committee: National Institute of 

Neurological Disorders and Stroke Special 

Emphasis Panel; Small Vessel VCID 

Biomarkers Validation Consortium Sites & 

Coordinating Center Review (U01 & U24). 

Date: June 25, 2021. 

Time: 10:30 a.m. to 6:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Neuroscience Center, 6001 Executive 

Boulevard, Rockville, MD 20852 (Virtual 

Meeting). 

Contact Person: Mir Ahamed Hossain, 

PhD, Scientific Review Officer, Scientific 

Review Branch, NINDS/NIH/DHHS, 

Neuroscience Center, 6001 Executive Blvd., 

Suite 3208, MSC 9529, Rockville, MD 20852, 

301–496–9223, mirahamed.hossain@nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.853, Clinical Research 

Related to Neurological Disorders; 93.854, 

Biological Basis Research in the 

Neurosciences, National Institutes of Health, 

HHS) 


jbell on DSKJLSW7X2PROD with NOTICES